Association between EPHX1 polymorphism rs1051740 and the risk of ovarian cancer: a meta-analysis

References

• Sehouli J, Alvarez AM, Manouchehrpour S, et al. A phase II trial of pemetrexed in combination with carboplatin in patients with recurrent ovarian or primary peritoneal cancer. Gynecol Oncol. 2012;124:205–209.
   PubMed Web of Science ®Google Scholar
• Schuler S, Lattrich C, Skrzypczak M, et al. Icb-1 gene polymorphism rs1467465 is associated with susceptibility to ovarian cancer. J Ovarian Res. 2014;7:42.
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
   PubMed Web of Science ®Google Scholar
• Chen LP, Cai PS, Liang HB. Association of the genetic polymorphisms of NFKB1 with susceptibility to ovarian cancer. Genet Mol Res. 2015;14:8273–8282. GMR.
   PubMed Web of Science ®Google Scholar
• Koensgen D, Bruennert D, Ungureanu S, et al. Polymorphism of the IL-8 gene and the risk of ovarian cancer. Cytokine 2015;71:334–338.
   PubMed Web of Science ®Google Scholar
• Romero I, Bast RC. Jr., Minireview: human ovarian cancer: biology, current management, and paths to personalizing therapy. Endocrinology. 2012;153:1593–1602.
   PubMed Web of Science ®Google Scholar
• Qin X, Ma L, Yang S, et al. The Asn680Ser polymorphism of the follicle stimulating hormone receptor gene and ovarian cancer risk: a meta-analysis. J Assist Reprod Genet. 2014;31:683–688.
   PubMed Web of Science ®Google Scholar
• Yuan C, Liu X, Yan S, et al. Analyzing association of the XRCC3 gene polymorphism with ovarian cancer risk. BioMed Res Int. 2014;2014:1.
   Web of Science ®Google Scholar
• Lu ZH, Gu XJ, Shi KZ, et al. Association between genetic polymorphisms of inflammatory response genes and the risk of ovarian cancer. J Formosan Med Assoc. 2015.
   Web of Science ®Google Scholar
• Jang JH, Cotterchio M, Borgida A, et al. Genetic variants in carcinogen-metabolizing enzymes, cigarette smoking and pancreatic cancer risk. Carcinogenesis. 2012;33:818–827.
   PubMed Web of Science ®Google Scholar
• Liu F, Yuan D, Wei Y, et al. Systematic review and meta-analysis of the relationship between EPHX1 polymorphisms and colorectal cancer risk. PloS One. 2012;7:e43821.
   PubMed Web of Science ®Google Scholar
• Li QT, Kang W, Wang M, et al. Association between esophageal cancer risk and EPHX1 polymorphisms: a meta-analysis. World J Gastroenterol. 2014;20:5124–5130.
   PubMed Web of Science ®Google Scholar
• Duan CY, Liu MY, Li SB, et al. Lack of association of EPHX1 gene polymorphisms with risk of hepatocellular carcinoma: a meta-analysis. Tumor Biol. 2014;35:659–666.
   PubMedGoogle Scholar
• Tan X, He WW, Wang YY, et al. EPHX1 Tyr113His and His139Arg polymorphisms in esophageal cancer risk: a meta-analysis. Genet Mol Res. 2014;13:649–659.
   PubMed Web of Science ®Google Scholar
• Lancaster JM, Brownlee HA, Bell DA, et al. Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer. Mol Carcinog. 1996;17:160–162.
   PubMed Web of Science ®Google Scholar
• Zintzaras E, Ioannidis JP. HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics. 2005;21:3672–3673.
   PubMed Web of Science ®Google Scholar
• Baxter SW, Choong DY, Campbell IG. Microsomal epoxide hydrolase polymorphism and susceptibility to ovarian cancer. Cancer Lett. 2002;177:75–81.
   PubMed Web of Science ®Google Scholar
• Goode EL, White KL, Vierkant RA, et al. Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk. Mol Carcinog. 2011;50:397–402.
   PubMed Web of Science ®Google Scholar
• Kang S, Duan LH, Li Y, et al. Relation Between microsomal epoxide hydrolase polymorphism and susceptibility to ovarian epithelial cancer. Zhonghua Fu Chan Ke Za Zhi. 2004;39:556–557.
   PubMedGoogle Scholar
• Spurdle AB, Purdie DM, Webb PM, et al. The microsomal epoxide hydrolase Tyr113His polymorphism: association with risk of ovarian cancer. Mol Carcinog. 2001;30:71–78.
   PubMed Web of Science ®Google Scholar
• Vaclavikova R, Hughes DJ, Soucek P. Microsomal epoxide hydrolase 1 (EPHX1): gene, structure, function, and role in human disease. Gene. 2015;571:8.
   Web of Science ®Google Scholar
• Nithipatikom K, Endsley MP, Pfeiffer AW, et al. A novel activity of microsomal epoxide hydrolase: metabolism of the endocannabinoid 2-arachidonoylglycerol. J Lipid Res. 2014;55:2093–2102.
   PubMed Web of Science ®Google Scholar
• El-Sherbeni AA, El-Kadi AO. The role of epoxide hydrolases in health and disease. Arch Toxicol. 2014;88:2013–2032.
   PubMed Web of Science ®Google Scholar
• Tumer TB, Sahin G, Arinc E. Association between polymorphisms of EPHX1 and XRCC1 genes and the risk of childhood acute lymphoblastic leukemia. Arch Toxicol. 2012;86:431–439.
   PubMed Web of Science ®Google Scholar
• Li H, Fu WP, Hong ZH. Microsomal epoxide hydrolase gene polymorphisms and risk of chronic obstructive pulmonary disease: a comprehensive meta-analysis. Oncol Lett. 2013;5:1022–1030.
   PubMed Web of Science ®Google Scholar
• Groten T, Schleussner E, Lehmann T, et al. eNOSI4 and EPHX1 polymorphisms affect maternal susceptibility to preeclampsia: analysis of five polymorphisms predisposing to cardiovascular disease in 279 Caucasian and 241 African women. Arch Gynecol Obstet. 2014;289:581–593.
   PubMed Web of Science ®Google Scholar
• Morisseau C, Bernay M, Escaich A, et al. Development of fluorescent substrates for microsomal epoxide hydrolase and application to inhibition studies. Anal Biochem. 2011;414:154–162.
   PubMed Web of Science ®Google Scholar
• Zhong JH, Zhang ZM, Li LQ. mEH Tyr113His polymorphism and the risk of ovarian cancer development. J Ovarian Res. 2013;6:40.
   PubMed Web of Science ®Google Scholar